Skip to content
Search

Latest Stories

Gisela Abbam reappointed as GPhC Chair

Gisela took on the role of GPhC chair in 2022

Gisela Abbam reappointed as GPhC chair

Gisela Abbam

Gisela Abbam has been reappointed as Chair of the General Pharmaceutical Council (GPhC) for a second term.

Previously, Gisela was Chair of the British Science Association (BSA). She took on the role of GPhC chair on 14 March 2022.


The Privy Council confirmed her reappointment, extending her tenure from 1 April 2025 until the end of March 2029.

Commenting on her reappointment, Gisela said: “I am delighted to be reappointed as chair and to continue to lead the important work being carried out at the GPhC.

“I understand that there are significant ongoing challenges for pharmacy and we will continue the listening exercise to provide whatever support we can.”

Gisela acknowledged that patients and their carers have been affected by medicines shortages, while pharmacy teams are grappling with workplace and financial pressures, impacting overall well-being.

She expressed appreciation for those working in pharmacy who are supporting their communities and helping people with their health needs while reaffirming the GPhC’s commitment to use all of its regulatory levers and influence to make a positive difference.

“Major reforms to health and social care are currently being discussed across England, Scotland and Wales.

“I aim to make sure pharmacy and pharmacy regulation is at the heart of those discussions, to ensure patients and the public get safe and effective care and have confidence in pharmacy now and in the future,” she added.

Elizabeth Mailey, a pharmacist member of Council, who was involved in the reappointment process, shared that Gisela has effectively led the Council to help drive forward their aims in her first term and has brought a real focus on “how the GPhC can support pharmacy, and the whole pharmacy team, to deliver improved care for patients and the public.”

“I am delighted that Gisela has been reappointed for a second term, so Gisela can continue to provide clear leadership as the GPhC finalises and implements its strategy for the next five years,” she said.

More For You

Pharmacist handing medicine to patient, NHS prescription cost freeze debate

Prescription charge will remain at £9.90

Pic credit: iStock

NPA calls for end to prescription charge after freeze announcement

The National Pharmacy Association (NPA) has asked for prescription charges to be completely removed despite the government announcing today that the charge will be frozen for the first time in three years.

Patients will continue paying £9.90 to collect their medication from a pharmacy.

Keep ReadingShow less
RPS launches new prescribing development programme for pharmacists

From 2026, every newly qualified pharmacist will be an independent prescriber

gettyimages

RPS unveils new training programme to enhance pharmacists’ prescribing skills

The Royal Pharmaceutical Society (RPS) has announced the launch of a comprehensive new prescribing development programme to support pharmacists across all stages of their prescribing careers.

The initiative comes ahead of the NHS mandate that every newly qualified pharmacist will be an independent prescriber by 2026 — a change set to transform the future of pharmacy practice.

Keep ReadingShow less
Varenicline promotes nicotine vaping cessation in young people

Researchers warn that e-cigarette use can increase risk for nicotine addiction,uptake of combusted tobacco and other substance use.

gettyimages

Anti-smoking pill varenicline may help young people quit vaping, new study suggests

Varenicline — a daily pill already offered through NHS Stop Smoking Services — could also support young people in quitting vaping, new research has suggested.

The medication, proven to be more effective than nicotine replacement gums or patches for smoking cessation, was shown to significantly boost vaping abstinence when combined with behavioural counselling in adolescents and young adults.

Keep ReadingShow less
Relying on blue inhalers alone can worsen asthma symptoms, warns MHRA

Patients are advised to use their preventer inhaler regularly, even if their asthma feels under control.

Pic credit: gettyimages

Overuse of blue inhalers can increase risk of severe asthma attacks, warns MHRA

The Medicines and Healthcare products Regulatory Agency (MHRA) is reminding asthma patients to use their preventer (anti-inflammatory) inhalers regularly as prescribed, rather than relying solely on their blue inhalers, also referred to as reliever inhalers.

“Without regular use of a preventer inhaler, symptoms could worsen and increase the risk of severe asthma attacks,” the MHRA warned.

Keep ReadingShow less
13 pharmacists achieve RPS core advanced credential with record pass rate

The latest successful cohort includes pharmacists from both England and Scotland.

Pic credit: Getty Images

13 more pharmacists achieve RPS core advanced credential - Highest pass rate yet

The Royal Pharmaceutical Society (RPS) has announced that 13 more pharmacists have successfully completed Core Advanced Credentialling as part of the latest assessment cohort —achieving a remarkable 93% pass rate, the highest to date.

This brings the total number of pharmacists awarded the RPS core advanced credential to 113 since the launch of the Core Advanced Curriculum in 2023, with successful candidates from GP, secondary care and community settings.

Keep ReadingShow less